Clinical trials in Petrzalka – page 2

Extensive clinical trials focusing on cardiovascular diseases and preventive treatments, including studies on atherosclerosis, myocardial infarction, and stroke prevention.

• Atherosclerotic cardiovascular disease treatments
• Acute myocardial infarction management
• Stroke prevention strategies

Novel therapies being evaluated include inclisiran and pelacarsen for reducing cardiovascular events.

Research initiatives targeting metabolic conditions, with particular emphasis on obesity, diabetes, and lipid disorders management.

• Type 2 diabetes treatments
• Obesity management
• Hypertriglyceridemia therapies

Studies evaluating new treatments like semaglutide and specialized medications for severe metabolic disorders.

Innovative research into autoimmune disorders, including trials for Sjögren's Syndrome, lupus, and chronic urticaria.

• Systemic Lupus Erythematosus treatments
• Primary Sjögren's Disease therapies
• Chronic urticaria management

Testing advanced biologics and targeted therapies for autoimmune condition management.

Clinical research focusing on neurological disorders and mental health conditions, including schizophrenia and neurogenic conditions.

• Schizophrenia treatment advances
• Neurogenic detrusor overactivity
• Pediatric neurological conditions

Evaluation of new therapeutic approaches for complex neurological disorders.